Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2003
03/12/2003EP1289495A1 Process for the preparation of a sterile ointment containing acyclovir
03/12/2003EP1289494A2 Powder compositions
03/12/2003EP1289493A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
03/12/2003EP1289487A1 Pre-formed sheet devices suitable for topical application
03/12/2003EP1289475A2 Water-thin emulsions with low emulsifier levels
03/12/2003EP1289474A2 Low emulsifier multiple emulsions
03/12/2003EP1196034B1 Antiparasitic formulation
03/12/2003EP1191927B1 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
03/12/2003EP1181018B1 Ziprasidone suspension
03/12/2003EP1131100B1 Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate
03/12/2003EP1103252B1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
03/12/2003EP1077726B1 Inhibiting undesirable taste in oral compositions
03/12/2003EP1041967B1 Microparticles and their therapeutic or diagnostic use
03/12/2003EP1009410B1 Method for producing stable acetylsalicylic acid solutions
03/12/2003EP0991415B1 Orally administrable solid ribavirin dosage forms and process for making them
03/12/2003EP0984773B1 Pharmaceutical formulation of omeprazole
03/12/2003EP0970705B1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both
03/12/2003EP0932396B1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
03/12/2003EP0914138B1 Complex preparations characterised by a betain content
03/12/2003EP0869783B1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/12/2003EP0735879B1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent.
03/12/2003EP0652754B1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
03/12/2003EP0274482B2 Isolated dna sequences associated with multidrug resistance in human cells
03/12/2003CN1402778A Elastic article
03/12/2003CN1402643A Integrin-mediated drug targeting
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402641A Pharmaceutical compositions of fibrinolytic agent
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1402636A Pharmaceutical formulations contg. zolmitriptan
03/12/2003CN1402633A Transdermal therapeutic system with improved stability and method for production thereof
03/12/2003CN1402632A Hydrogel-driven drug dosage form
03/12/2003CN1402630A Novel pharmaceutical compositions
03/12/2003CN1402629A Pharmaceutical compositions providing enhanced drug concentrations
03/12/2003CN1402616A Addition of tetracyclines to animal foodstuffs
03/12/2003CN1401391A Use of casein and polypeptide in Chinese herbal medicine/Chinese patent medicine
03/12/2003CN1401325A Pharmaceutical composition
03/12/2003CN1401257A Chewing gum component for eliminating nicotine
03/12/2003CN1102854C Composition for sustained release of human growth hormone
03/12/2003CN1102852C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs
03/12/2003CN1102850C Percutaneously absorbable preparation
03/11/2003USRE38027 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
03/11/2003US6531508 Antibacterial medicinal compositions
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531500 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering by administering an oil-in-water emulsion comprising: (a) allantoin; and (b) an emulsifier system including beeswax and an anionic emulsifier
03/11/2003US6531458 Stable formulation for oral administration
03/11/2003US6531448 Composition comprising protein selected from insulin, insulin analog, and proinsulin; derivatized protein selected from fatty acid-acylated insulins; complexing compound; hexamer stabilizing compound; and divalent metal cation
03/11/2003US6531445 Protein-induced morphogenesis in liver tissue
03/11/2003US6531160 Microcapsules with an aqueous core containing at least one water-soluble cosmetic or dermatological active principle and cosmetic or dermatological compositions containing them
03/11/2003US6531155 Granular materials obtainable by pressing mixtures of at least one pulverulent, rheology- modifying, carboxyl-containing polymer as main component and at least one oil-soluble component
03/11/2003US6531143 α-hydroxy fatty acid derivatives and external compositions containing the same
03/11/2003US6531139 Self-emulsifying formulation for lipophilic compounds
03/11/2003US6531126 Animal derived lipid
03/11/2003CA2177696C Lipid vesicles containing avocado oil unsaponifiables
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/06/2003WO2003018743A2 Emu-based formulations for wound treatment
03/06/2003WO2003018690A1 Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these
03/06/2003WO2003018665A1 Process for the preparation of activated polyethylene glycols
03/06/2003WO2003018639A1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018609A2 Application of peptide conjugates to alzheimer's disease
03/06/2003WO2003018603A1 Aminoglycoside lipid derivatives for transfection
03/06/2003WO2003018539A1 Amphoteric lipid compound and use thereof
03/06/2003WO2003018186A1 Stable coated microcapsules
03/06/2003WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003WO2003018075A2 Transdermal therapeutic system with fentanyl or related substances
03/06/2003WO2003018071A1 Transdermal therapeutic system (tts) with fentanyl as active ingredient
03/06/2003WO2003018065A1 Anti-cancer agents comprising disintegrin genes and the treating methods
03/06/2003WO2003018064A2 Lipophilic drug compositions
03/06/2003WO2003018063A1 Composition of a carrier substance for products based on papain and hyaluronidase
03/06/2003WO2003018062A1 Improved therapeutic protocols
03/06/2003WO2003018056A1 Stabilized preparations containing antibody
03/06/2003WO2003018054A1 Helicobacter pylori vaccination
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018046A1 Crystals of luxp and complexes thereof
03/06/2003WO2003018045A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof
03/06/2003WO2003018023A1 Compositions and methods for targeting cerebral circulation and treatment of headache
03/06/2003WO2003018016A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
03/06/2003WO2003018007A1 Antitumor agents and process for producing the same
03/06/2003WO2003017991A2 Injection solution containing a dihydropyridin derivative
03/06/2003WO2003017990A2 Ophthalmic composition comprising an ascomycin
03/06/2003WO2003017989A1 Compositions and techniques for localized therapy of restenosis
03/06/2003WO2003017988A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
03/06/2003WO2003017986A1 Compositions containing itraconazole and their preparation methods
03/06/2003WO2003017983A1 A new extended release oral dosage form
03/06/2003WO2003017982A1 A new extended release oral dosage form
03/06/2003WO2003017977A1 Anaesthetic formulations of propofol
03/06/2003WO2003017976A1 Synergistic mixed poloxamer systems for the solubilisation of drugs
03/06/2003WO2003017975A2 Method for producing solutions
03/06/2003WO2003017972A2 Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers)
03/06/2003WO2003017971A1 Drug delivery system
03/06/2003WO2003017947A2 Spontaneous emulsions containing cyclosporine
03/06/2003WO2003017943A2 Therapeutic compositions and methods for treating viral infection
03/06/2003WO2003017941A2 Flexible applicator for applying oil-in-water emulsion with improved stability
03/06/2003WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
03/06/2003WO2003017938A2 Conjugates targeted to target receptors
03/06/2003WO2003017932A2 Compositions and methods for targeting cerebral circulation and treatment of headache
03/06/2003WO2003017923A2 Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same
03/06/2003WO2003017921A2 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes
03/06/2003WO2003017824A2 Method and apparatus for acne treatment
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1712